Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.95 - $4.04 $1,875 - $3,886
-962 Reduced 28.81%
2,377 $6,000
Q4 2023

Feb 13, 2024

SELL
$2.32 - $5.51 $44,425 - $105,510
-19,149 Reduced 85.15%
3,339 $9,000
Q3 2023

Nov 14, 2023

SELL
$2.49 - $11.85 $4,369 - $20,796
-1,755 Reduced 7.24%
22,488 $56,000
Q2 2023

Aug 21, 2023

SELL
$6.39 - $28.58 $632 - $2,829
-99 Reduced 0.41%
24,243 $161,000
Q1 2023

May 09, 2023

SELL
$17.7 - $33.24 $5,717 - $10,736
-323 Reduced 1.31%
24,342 $454,000
Q4 2022

Feb 14, 2023

BUY
$10.25 - $22.43 $2,654 - $5,809
259 Added 1.06%
24,665 $529,000
Q3 2022

Nov 18, 2022

SELL
$11.19 - $17.89 $772 - $1,234
-69 Reduced 0.28%
24,406 $288,000
Q2 2022

Aug 15, 2022

BUY
$9.03 - $21.55 $1,932 - $4,611
214 Added 0.88%
24,475 $323,000
Q1 2022

May 16, 2022

SELL
$15.0 - $22.83 $23,850 - $36,299
-1,590 Reduced 6.15%
24,261 $507,000
Q4 2021

Feb 15, 2022

BUY
$20.12 - $35.09 $13,138 - $22,913
653 Added 2.59%
25,851 $526,000
Q3 2021

Nov 15, 2021

BUY
$23.84 - $32.03 $98,387 - $132,187
4,127 Added 19.59%
25,198 $765,000
Q2 2021

Aug 16, 2021

BUY
$29.06 - $38.83 $52,308 - $69,894
1,800 Added 9.34%
21,071 $612,000
Q1 2021

May 18, 2021

SELL
$39.04 - $64.6 $2,264 - $3,746
-58 Reduced 0.3%
19,271 $832,000
Q4 2020

Feb 16, 2021

BUY
$42.46 - $56.58 $67,384 - $89,792
1,587 Added 8.94%
19,329 $893,000
Q3 2020

Nov 17, 2020

BUY
$37.44 - $64.63 $66,755 - $115,235
1,783 Added 11.17%
17,742 $769,000
Q2 2020

Aug 17, 2020

BUY
$17.62 - $58.71 $103,499 - $344,862
5,874 Added 58.24%
15,959 $846,000
Q1 2020

May 13, 2020

BUY
$12.26 - $41.14 $9,844 - $33,035
803 Added 8.65%
10,085 $225,000
Q2 2019

Aug 14, 2019

BUY
$8.99 - $11.79 $83,445 - $109,434
9,282 New
9,282 $102,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $66.7M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.